Regulation of chemokine and chemokine receptor expression by PPARγ in adipocytes and macrophages

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Nguyen, M T Audrey ^a   Chen, Ai ^a   Lu, Wendell J ^a   Fan, WuQiang ^a   Li, Ping Ping ^a   Oh, Da Young ^a   Patsouris, David ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CHEMOKINE; CHEMOKINE RECEPTOR; FATTY ACID; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE; TOLL LIKE RECEPTOR 4;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CHEMOTAXIS; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENDOPLASMIC RETICULUM STRESS; EPIDIDYMIS FAT; GENE; GENE EXPRESSION REGULATION; GENE SILENCING; INFLAMMATION; MACROPHAGE; MALE; MCP1 GENE; MOUSE; NONHUMAN; OBESITY; PROTEIN EXPRESSION; PROTEIN SECRETION; UPREGULATION;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; ARACHIDONIC ACID; CHEMOKINES; CHEMOTACTIC FACTORS; DOWN-REGULATION; ENDOPLASMIC RETICULUM STRESS; FATTY ACIDS, NONESTERIFIED; GENE EXPRESSION; HYPOGLYCEMIC AGENTS; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; PPAR GAMMA; RECEPTORS, CHEMOKINE; SIGNAL TRANSDUCTION; THIAZOLIDINEDIONES; TOLL-LIKE RECEPTOR 4;

EID: 84859822353     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034976     Document Type: Article

References (53)

1. Hirabara SM, Silveira LR, Abdulkader F, Carvalho CR, Procopio J, et al. (2007) Time-dependent effects of fatty acids on skeletal muscle metabolism. J Cell Physiol 210: 7-15.
2. Lee JY, Plakidas A, Lee WH, Heikkinen A, Chanmugam P, et al. (2003) Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids. J Lipid Res 44: 479-486.
3. Nguyen MT, Favelyukis S, Nguyen AK, Reichart D, Scott PA, et al. (2007) A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. J Biol Chem 282: 35279-35292.
4. Solinas G, Vilcu C, Neels JG, Bandyopadhyay GK, Luo JL, et al. (2007) JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. Cell Metab 6: 386-397.
5. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, et al. (2006) TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116: 3015-3025.
6. Schenk S, Saberi M, Olefsky JM, (2008) Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest 118: 2992-3002.
7. Jiao P, Ma J, Feng B, Zhang H, Alan Diehl J, et al. (2011) FFA-induced adipocyte inflammation and insulin resistance: involvement of ER stress and IKKbeta pathways. Obesity (Silver Spring) 19: 483-491.
8. Hotamisligil GS, (2010) Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140: 900-917.
9. Nguyen MT, Satoh H, Favelyukis S, Babendure JL, Imamura T, et al. (2005) JNK and tumor necrosis factor-alpha mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes. J Biol Chem 280: 35361-35371.
10. Jiao P, Chen Q, Shah S, Du J, Tao B, et al. (2009) Obesity-related upregulation of monocyte chemotactic factors in adipocytes: involvement of nuclear factor-kappaB and c-Jun NH2-terminal kinase pathways. Diabetes 58: 104-115.
11. Yeop Han C, Kargi AY, Omer M, Chan CK, Wabitsch M, et al. (2010) Differential effect of saturated and unsaturated free fatty acids on the generation of monocyte adhesion and chemotactic factors by adipocytes: dissociation of adipocyte hypertrophy from inflammation. Diabetes 59: 386-396.
12. Patsouris D, Neels JG, Fan W, Li PP, Nguyen MT, et al. (2009) Glucocorticoids and thiazolidinediones interfere with adipocyte-mediated macrophage chemotaxis and recruitment. J Biol Chem 284: 31223-31235.
13. Sun K, Kusminski CM, Scherer PE, (2011) Adipose tissue remodeling and obesity. J Clin Invest 121: 2094-2101.
14. Hevener AL, He W, Barak Y, Le J, Bandyopadhyay G, et al. (2003) Muscle-specific Pparg deletion causes insulin resistance. Nat Med 9: 1491-1497.
15. Hevener AL, Olefsky JM, Reichart D, Nguyen MT, Bandyopadyhay G, et al. (2007) Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones. J Clin Invest 117: 1658-1669.
16. Barak Y, Nelson MC, Ong ES, Jones YZ, Ruiz-Lozano P, et al. (1999) PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell 4: 585-595.
17. Tontonoz P, Hu E, Devine J, Beale EG, Spiegelman BM, (1995) PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol Cell Biol 15: 351-357.
18. Semple RK, Chatterjee VK, O'Rahilly S, (2006) PPAR gamma and human metabolic disease. J Clin Invest 116: 581-589.
19. Kersten S, Desvergne B, Wahli W, (2000) Roles of PPARs in health and disease. Nature 405: 421-424.
20. Desvergne B, Wahli W, (1999) Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 20: 649-688.
21. Choi JH, Banks AS, Estall JL, Kajimura S, Bostrom P, et al. Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5. Nature 466: 451-456.
22. Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, et al. (1995) A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 83: 813-819.
23. Patsouris D, Muller M, Kersten S, (2004) Peroxisome proliferator activated receptor ligands for the treatment of insulin resistance. Curr Opin Investig Drugs 5: 1045-1050.
24. Hevener AL, Reichart D, Olefsky J, (2000) Exercise and thiazolidinedione therapy normalize insulin action in the obese Zucker fatty rat. Diabetes 49: 2154-2159.
25. Straus DS, Pascual G, Li M, Welch JS, Ricote M, et al. (2000) 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. Proc Natl Acad Sci U S A 97: 4844-4849.
26. Ogawa S, Lozach J, Benner C, Pascual G, Tangirala RK, et al. (2005) Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell 122: 707-721.
27. Gregoire FM, Zhang F, Clarke HJ, Gustafson TA, Sears DD, et al. (2009) MBX-102/JNJ39659100, a novel peroxisome proliferator-activated receptor-ligand with weak transactivation activity retains antidiabetic properties in the absence of weight gain and edema. Mol Endocrinol 23: 975-988.
28. Pascual G, Sullivan AL, Ogawa S, Gamliel A, Perissi V, et al. (2007) Anti-inflammatory and antidiabetic roles of PPARgamma. Novartis Found Symp 286: 183-196; discussion 196-203.
29. Liao W, Nguyen MT, Yoshizaki T, Favelyukis S, Patsouris D, et al. (2007) Suppression of PPAR-gamma attenuates insulin-stimulated glucose uptake by affecting both GLUT1 and GLUT4 in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 293: E219-227.
30. Ruan H, Pownall HJ, Lodish HF, (2003) Troglitazone antagonizes tumor necrosis factor-alpha-induced reprogramming of adipocyte gene expression by inhibiting the transcriptional regulatory functions of NF-kappaB. J Biol Chem 278: 28181-28192.
31. He W, Barak Y, Hevener A, Olson P, Liao D, et al. (2003) Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle. Proc Natl Acad Sci U S A 100: 15712-15717.
32. Imai T, Takakuwa R, Marchand S, Dentz E, Bornert JM, et al. (2004) Peroxisome proliferator-activated receptor gamma is required in mature white and brown adipocytes for their survival in the mouse. pp. 4543-4547 Proc Natl Acad Sci U S A.
33. Zhu Y, Qi C, Korenberg JR, Chen XN, Noya D, et al. (1995) Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms. Proc Natl Acad Sci U S A 92: 7921-7925.
34. Camp HS, Whitton AL, Tafuri SR, (1999) PPARgamma activators down-regulate the expression of PPARgamma in 3T3-L1 adipocytes. FEBS Lett 447: 186-190.
35. Fan W, Imamura T, Sonoda N, Sears DD, Patsouris D, et al. (2009) FOXO1 transrepresses peroxisome proliferator-activated receptor gamma transactivation, coordinating an insulin-induced feed-forward response in adipocytes. J Biol Chem 284: 12188-12197.
36. Martinon F, Chen X, Lee AH, Glimcher LH, (2010) TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages. Nat Immunol 11: 411-418.
37. Liu N, Liu JT, Ji YY, Lu PP, (2010) C-reactive protein triggers inflammatory responses partly via TLR4/IRF3/NF-kappaB signaling pathway in rat vascular smooth muscle cells. Life Sci 87: 367-374.
38. Oh DY, Talukdar S, Bae EJ, Imamura T, Morinaga H, et al. (2010) GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142: 687-698.
39. Lumeng CN, Bodzin JL, Saltiel AR, (2007) Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117: 175-184.
40. Patsouris D, Li PP, Thapar D, Chapman J, Olefsky JM, et al. (2008) Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab 8: 301-309.
41. Lumeng CN, DelProposto JB, Westcott DJ, Saltiel AR, (2008) Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes. Diabetes 57: 3239-3246.
42. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, et al. (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25: 677-686.
43. Suganami T, Nishida J, Ogawa Y, (2005) A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler Thromb Vasc Biol 25: 2062-2068.
44. Suganami T, Tanimoto-Koyama K, Nishida J, Itoh M, Yuan X, et al. (2007) Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol 27: 84-91.
45. Odegaard JI, Chawla A, (2011) Alternative macrophage activation and metabolism. Annu Rev Pathol 6: 275-297.
46. Ron D, Habener JF, (1992) CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. Genes Dev 6: 439-453.
47. Park SH, Choi HJ, Yang H, Do KH, Kim J, et al. (2010) Endoplasmic reticulum stress-activated C/EBP homologous protein enhances nuclear factor-kappaB signals via repression of peroxisome proliferator-activated receptor gamma. J Biol Chem 285: 35330-35339.
48. Wu Z, Xie Y, Bucher NL, Farmer SR, (1995) Conditional ectopic expression of C/EBP beta in NIH-3T3 cells induces PPAR gamma and stimulates adipogenesis. Genes Dev 9: 2350-2363.
49. Chung S, Lapoint K, Martinez K, Kennedy A, Boysen Sandberg M, et al. (2006) Preadipocytes mediate lipopolysaccharide-induced inflammation and insulin resistance in primary cultures of newly differentiated human adipocytes. Endocrinology 147: 5340-5351.
50. Sears DD, Hsiao A, Ofrecio JM, Chapman J, He W, et al. (2007) Selective modulation of promoter recruitment and transcriptional activity of PPARgamma. Biochem Biophys Res Commun 364: 515-521.
51. McClelland S, Cox C, O'Connor R, de Gaetano M, McCarthy C, et al. (2010) Conjugated linoleic acid suppresses the migratory and inflammatory phenotype of the monocyte/macrophage cell. Atherosclerosis 211: 96-102.
52. Sears DD, Miles PD, Chapman J, Ofrecio JM, Almazan F, et al. (2009) 12/15-lipoxygenase is required for the early onset of high fat diet-induced adipose tissue inflammation and insulin resistance in mice. PLoS One 4: e7250.
53. Inouye KE, Shi H, Howard JK, Daly CH, Lord GM, et al. (2007) Absence of CC chemokine ligand 2 does not limit obesity-associated infiltration of macrophages into adipose tissue. Diabetes 56: 2242-2250.